active

Funding Opportunity: 25-06-ExMedModernize "Modernization of Expeditionary Medicine (EXMED) Warfighter Prototypes"

Medical Technology Enterprise Consortium (MTEC)

REQUEST ISSUE DATE

May 20, 2025

ENHANCED WHITEPAPER DUE

June 13, 2025


Purpose

This solicitation, issued by the MTEC Consortium Manager (CM), Advanced Technology International (ATI), represents a Request for Project Proposals (RPP) for MTEC in support of the Defense Health Agency and Program Executive Office, Unmanned and Small Combatants (PEO USC) Expeditionary Missions (EXM) (PMS 408). Military relevance is a critical component of the Enhanced White Paper submission. Strategic oversight for the award(s) supported by this RPP will be provided by PMS 408.


This RPP is focused on creating a systems integration approach to developing an array of medical solutions related to evaluating and optimizing Warfighter prototypes for forward stabilization, resuscitative care, primary care, dental services and force health protection in support of the modernization of expeditionary medicine (EXMED), in particular for implementation on the newly envisioned navy Expeditionary Fast Transport (EPF) ships. These new EPF ships for medical are able to receive and treat casualties in littoral areas to meet mission requirements of a distributed maritime operation and expeditionary advanced base operations, which is anticipated in future conflicts with peer competitors. Role 2 (R2) care and advanced surgical support afloat in littoral conditions is currently not a Naval capability.

Current medical technologies are inadequate for surgical care aboard an EPF Flight II platform, not interoperable, and do not meet the requirements of the EXMED family of systems (FoS) Capabilities Development Document (CDD). Therefore, this prototype project is an innovative business arrangement for a system integrator to identify and rapidly test these expeditionary medical solutions. This RPP aims to establish an agreement with an organization able to provide the integration of technology, resources and expertise required to translate technologies related to Warfighter expeditionary medicine through the required development activities to transition to the Warfighter and the commercial marketplace. This RPP also intends to fund several prototypes to be advanced with this initial RPP, and includes the innovative business component of identifying, rapidly prototyping and testing additional medical solutions related to expeditionary medicine.


In order to modernize the DoD to be a ready and resilient Force, PMS 408 is seeking to build a capability through MTEC that is poised to rapidly advance prototypes related to Warfighter expeditionary medicine and transition these to both the Warfighter and the commercial marketplace as appropriate. This effort requires multiple prototype solutions (hereafter referred to as EXMED technologies) that address forward stabilization, resuscitative care, primary care, dental services and force health protection.

Funding Availability: The U.S. Government (USG) currently has available a total of approximately $800,000 for this effort, for direct and indirect costs.

Number of anticipated awards: MTEC expects to make a single award to a qualified Offeror to accomplish the scope of work.

Period of performance: The period of performance (PoP) is not to exceed 18 months.

To view the full-length version of this RPP, please download using the link on this page.

Scope of Work

Technical Requirements
Background


EXMED solutions are intended to be mobile, resilient, modular, scalable, and extensible capabilities that ensure uninterrupted and secure HCD within medical units and throughout the continuum of care as well as enable MEDC2/MEDLOG and PM (e.g., medical regulating) functionality. Current wartime operations assume that the United States and our allies will maintain air, land, maritime, space and cyber superiority. Future conflicts against peer and near-peer adversaries are expected to be layered stand-offs and fought across multiple domains. Mission success will be determined by our ability to compete to expand the competitive space, penetrate both strategically and operationally, disintegrate enemy’s defenses, exploit enemy weaknesses, and re-compete to consolidate gains. Medical capabilities play a critical role in each aspect of the future battlespace and must modernize rapidly to maintain Force readiness and increase soldier lethality.


Naval forces must be able to coordinate and execute highly distributed operations over oceanic distances. Distributed naval forces and increased adversary lethality require distributed and tailorable medical capabilities. These capabilities must be modular, scalable, and adaptable to various platforms and facilities to ensure forces have access to flexible and agile medical capabilities that enable timely response. The Program Executive Office, Unmanned and Small Combatants (PEO USC) Expeditionary Missions (EXM) (PMS 408) seeks to overcome the medical and logistical challenges present in these environments by providing forward stabilization, resuscitative care, primary care, dental services, and force health protection capabilities to Naval Operating Forces during contingency and/or large-scale combat operations (LSCO).


Within PMS408, the government has developed initial concept prototypes related to En Route Care Systems (ERCS), Expeditionary Resuscitative Surgical Systems (ERSS), Expeditionary Medical Units (EMU), Ashore Theater Hospitalization Systems (ATHS), Certified Diagnostic Mobile Laboratories (CDML) and other Forward-Deployable Preventive Medicine Units [FDPMU; and Certified Diagnostic Mobile Laboratory (CDML)], as well as the information technology system/s required for patient movement. Each of these provide an aspect of the overall capability set for the EXMED family of systems (FOS). For example, ERCS provides patient movement in the theater of operations. ATHS offers an agile R3 capability. Given the tyranny of distance in LSCO, R2 and R3 capabilities must be readily accessible (i.e., within range of ERCS) to ensure quick life-saving treatment and movement of patients to the next level of care (e.g. R1 to R2 care). Pre-positioned and accessible R2 and R3 assets can also support timely resupply of ERCS. Together, these capabilities, as well as materiel solutions, enable and enhance first responder care and delayed evacuation care.


Objective
In order to modernize the DoD to be a ready and resilient Force, PMS 408 is seeking to build a capability through MTEC that is poised to rapidly advance prototypes related to Warfighter expeditionary medicine and transition these to both the Warfighter and the commercial marketplace as appropriate. This effort requires multiple prototype solutions (hereafter referred to as EXMED technologies) that address forward stabilization, resuscitative care, primary care, dental services and force health protection.


Solution Requirement
The U.S. Government is seeking the solutions capable of satisfying the following capabilities:


Task 1 – Prime Integrator capabilities to translate prototypes. The project shall be led by an “integrator” proficient at leveraging capabilities available to advance these prototypes in coordination with PMS 408. Due to the Integrator’s specialized expertise, this approach will de-risk technology development by providing capability/expertise to successfully optimize and implement these technologies in an expeditionary medicine setting. The integrator will work closely with PMS 408 to incorporate service member feedback into the testing/evaluating process, while continually synchronizing and integrating efforts to optimize prototype development. In coordination with the PMS 408 PMO and stakeholders, the Integrator will conduct evaluation and testing of the PMS 408 project portfolio to determine potential candidate expeditionary medicine technology prototypes for Fleet modernization efforts within the EXMED capabilities.

Task 1 includes the following:

  1. Develop detailed test plans for required EXMED Capabilities that meet Requirements in CDD.
  2. Conduct survey of Fleet Exercises and outline plans and activities by fiscal year for targeted opportunities to conduct evaluations and testing of prototypes that meet CDD Requirements.
  3. Develop working groups or regular meetings with EXM Capability Stakeholders within Naval Medicine Enterprise to ensure collaboration among partner commands exists (e.g. Navy Medicine manning requirements at tests).
  4. Outline areas of acceptance and concern within EXM Capabilities that need addressed through government resourcing for modernization or replacement of technology/technologies encompassing EXMED Capabilities based on results of independent evaluation and testing.
  5. Develop detailed test reports for EXMED Capabilities upon completion of evaluation and testing for PMS 408 review.

Task 2 – Development, Optimization, Implementation of EXMED technology prototypes. Implement optimization activities to modernize candidate prototype projects according to the EXMED CDD specifications:

  • Utilize performer resources or methodologies to advance candidate technology prototypes for implementation in the modernized expeditionary medicine environment (i.e., PMS 408 FoS). Modernization efforts may include, but are not limited to:
    • Clinical Testing
    • Biocompatibility studies
    • Prototype refinement/maturation progressing toward a clinical product
    • Stability and shelf-life studies
    • Prototype delivery for military-relevant testing
    • Development of DoD 5000 documentation and activities to support acquisition maturation

Potential Follow-on Tasks
Under awards resulting from this RPP, there is the potential for award of one or more non-competitive follow-on tasks based on the success of the project (subject to change depending upon Government review of completed work and successful progression of milestones). Potential follow-on work may be awarded based on the advancement in prototype maturity during the initial PoP. Follow-on work may include increasing the number of prototypes evaluated, optimized and modernized by the Integrator, and advancing technical testing in relevant or simulated operational environments.

Proposers Conference

MTEC intends to host a Proposers Conference that will be conducted via virtual webinar on May 30, 2025, at 12:00pm (Noon) EST. The intent of the Proposers Conference is to provide an administrative overview of this RPP process to award and present further insight into the Technical Requirements outlined in Section 3 of this RPP. To register for this conference, please use this link: https://ati.zoomgov.com/webinar/register/WN_oXhaILIJRUmkJn3OsSshWQ.

Points of Contact

For inquiries, please direct your correspondence to the following contacts:

  • Questions concerning contractual, cost or pricing related to this RPP should be directed to the MTEC Contracts Manager, Ms. Taylor Hummell, mtec-contracts@ati.org
  • Technical and membership questions should be directed to the MTEC Biomedical Research Associate, Dr. Chuck Hutti, Ph.D., chuck.hutti@ati.org
  • All other questions should be directed to the MTEC Program Manager, Mr. Evan Kellinger, mtec-sc@ati.org

Other Opportunities